Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020;152(1 & 2):156-163.
doi: 10.4103/ijmr.IJMR_3640_20.

Revisiting regulatory framework in India for accelerated vaccine development in pandemics with an evidence-based fast-tracking strategy

Amit Kumar Dinda  1 , Santanu Kumar Tripathi  2 , Bobby John  3
Affiliations

Revisiting regulatory framework in India for accelerated vaccine development in pandemics with an evidence-based fast-tracking strategy

Amit Kumar Dinda et al. Indian J Med Res. 2020.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None.

Figures

Figure
Figure
Adaptive model for vaccine development in public health emergency contexts.
See this image and copyright information in PMC

References

    1. Pregelj L, Hine DC, Oyola-Lozada MG, Munro TP. Working hard or hardly working? Regulatory bottlenecks in developing a COVID-19 vaccine. Trends Biotechnol. 2020;38:943–7. - PMC - PubMed
    1. World Health Organization. Draft landscape of COVID-19 candidate vaccines. [accessed on August 28, 2020]. Available from: https://wwwwhoint/publications/m/item/draft-landscape-of-covid-19-candid... .
    1. Lurie N, Saville M, Hatchett R, Halton J. Developing COVID-19 vaccines at pandemic speed. N Engl J Med. 2020;382:1969–73. - PubMed
    1. Hanney SR, Wooding S, Sussex J, Grant J. From COVID-19 research to vaccine application: Why might it take 17 months not 17 years and what are the wider lessons? Health Res Policy Syst. 2020;18:61. - PMC - PubMed
    1. Lythgoe MP, Middleton P. Ongoing clinical trials for the management of the COVID-19 pandemic. Trends Pharmacol Sci. 2020;41:363–82. - PMC - PubMed